CyGene Laboratories logo — Pioneering the Future of Diagnostics and Therapies for Human...

CyGene Laboratories

Pioneering the Future of Diagnostics and Therapies for Human, Veterinary, and Plant Health

Founded 1986 11-50 employees Biotechnology, Health Care

General Information

Company Name CyGene Laboratories
Founded Year 1986
Employees 11-50
Industries Biotechnology, Health Care
Social

Get notified when CyGene Laboratories moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CyGene Laboratories

CyGene Laboratories is a biotechnology company that has been pioneering the Future of Diagnostics and Therapies for Human, Veterinary, and Plant Health since its establishment in 1986. The company is focused on the development and commercialization of genetic and diagnostic testing, as well as treatments for infectious, genetic, and autoimmune diseases. Their proprietary DNA and RNA testing systems are designed for screening, monitoring, and diagnosing various human, veterinary, and plant diseases. One of their notable products is the Strategic Target Elimination (STE) system, an antibody-based technology that is capable of removing microbiological, viral, and chemical agents from the bloodstream. Additionally, the STE system can function as a pseudo-vaccine, providing protection to an individual for around 60 days. CyGene Laboratories operates within the Biotechnology and Health Care industries. Although specific details about their headquarters and recent investments are not available, the company's focus on innovative diagnostic and therapeutic solutions positions it as an intriguing prospect for venture capital investment. The potential to address a wide range of human, veterinary, and plant health challenges through their technologies makes CyGene Laboratories an attractive opportunity for investors seeking to support groundbreaking advancements in biotechnology and healthcare.

Taxonomy: genetic testing, diagnostic testing, therapies, infectious diseases, autoimmune diseases, veterinary health, plant health, DNA testing, RNA testing, antibody-based technology, vaccine development, microbiology, virology, chemical agents

No funding data available for CyGene Laboratories yet.

Get notified when CyGene Laboratories raises funding

CyGene Laboratories Alternatives & Competitors

CyGene Laboratories vs

Empowering health with advanced solutions against liver disease and comprehensive molecular testing...

46 employees
Biotechnology, Health Care
CyGene Laboratories vs

Revolutionizing Molecular Diagnostics with world-class Innovative IVD Solutions.

103 employees
Biotechnology, Health Care
CyGene Laboratories vs

Genetic Diseases Diagnostic Center

34 employees

FAQ About CyGene Laboratories

Pioneering the Future of Diagnostics and Therapies for Human, Veterinary, and Plant Health
CyGene Laboratories was founded in 1986.
CyGene Laboratories operates in the following industries: Biotechnology, Health Care.
CyGene Laboratories has approximately 11-50 employees.
Top alternatives and competitors to CyGene Laboratories include 福建广生堂药业股份有限公司, G2M | Next Generation IVD solutions for Genomics, Sapiens Genetics, CENTOGENE, Dia4Me. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CyGene Laboratories and 福建广生堂药业股份有限公司 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CyGene Laboratories and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy